Upcoming Program
- Preparing for What’s Next in U.S. Health Reform (5/31-6/2) Join me at Harvard for a deep dive into the details of the future U.S. health reform with the nation’s leading experts.
Tag Archives: Germany
Want Drug Pricing Regulation? Why Not AMNOG?
[This article was posted on December 29th 2016 on the Health Affairs blog. It was co-written with Dr. Karl Lauterbach, the Deputy Leader of the Social Democratic Party in the German Bundestag, and Dr. Elizabeth Seeley of the Harvard Chan … Continue reading
Posted in Global Health Policy, Health Policy, National Health Policy
Tagged AMNOG, drug pricing regulation, Germany, IQWIG, Karl Lauterbach, PCORI
Leave a comment
